A lethal, drug-resistant hospital fungus might lastly have a weak point—and scientists assume they’ve discovered it.
Researchers have recognized a genetic course of that would open the door to new remedies for a harmful fungal an infection that has repeatedly pressured hospital intensive care models to shut. The invention provides contemporary hope towards a pathogen that has been tough to manage and even tougher to deal with.
Candida auris poses a critical menace to people who find themselves already critically sick, making hospitals notably weak to outbreaks. Though the fungus can exist harmlessly on the pores and skin of many individuals, sufferers who depend on ventilators face a a lot increased threat of an infection. As soon as it takes maintain, the illness kills round 45 per cent of these contaminated and may face up to each main class of antifungal treatment. This mix has made it extraordinarily difficult to get rid of from hospital wards as soon as it spreads.
A worldwide well being menace on the rise
Candida auris was first recognized in 2008, and scientists nonetheless have no idea the place it initially got here from. Since its discovery, outbreaks have been reported in additional than 40 nations, together with the UK. The fungus, also referred to as Candidozyma auris, is now acknowledged as a worldwide well being menace and seems on the World Well being Group’s crucial precedence fungal pathogens record. Within the UK, case numbers have continued to climb over time.
Finding out an infection in a dwelling host
For the primary time, a staff on the College of Exeter has intently examined how Candida auris prompts its genes throughout an infection utilizing an modern experimental mannequin primarily based on fish larvae. The analysis was printed within the Nature portfolio journal Communications Biology and obtained help from Wellcome, the Medical Analysis Council (MRC), and the Nationwide Middle for Substitute, Discount and Refinement (NC3Rs).
The outcomes recommend a promising path towards figuring out a organic goal that could possibly be used to develop new antifungal medicine or adapt present ones, offered the identical genetic exercise happens throughout an infection in people.
The work was co-led by NIHR Medical Lecturer Hugh Gifford from the College of Exeter’s MRC Middle for Medical Mycology (CMM). He mentioned: “Because it emerged, Candida auris has wreaked havoc the place it takes maintain in hospital intensive care models. It may be lethal for weak sufferers, and well being trusts have spent thousands and thousands on the tough job of eradication. We predict our analysis might have revealed an Achilles heel on this deadly pathogen throughout energetic an infection, and we urgently want extra analysis to discover whether or not we are able to discover medicine that concentrate on and exploit this weak point.”
Why a brand new mannequin was wanted
One long-standing problem in learning Candida auris is its potential to outlive excessive temperatures. Mixed with its unusually sturdy tolerance to salt, this has led some scientists to take a position that it could have originated in tropical oceans or marine animals. These traits have additionally made it tougher to check utilizing conventional laboratory fashions.
To beat this, the Exeter researchers developed a brand new system utilizing Arabian killifish, whose eggs are capable of survive at human physique temperature. This allowed the staff to watch the an infection course of in a dwelling host underneath lifelike circumstances.
Genetic clues to survival and unfold
In the course of the research, the researchers noticed that Candida auris can shift into elongated fungal buildings known as filaments, which can assist it seek for vitamins contained in the host.
In addition they tracked which genes had been turned on and off throughout an infection, highlighting potential weaknesses. A number of of the activated genes are concerned in producing nutrient pumps that seize iron-scavenging molecules and pull iron into fungal cells. Iron is important for survival, and this dependence may signify a crucial vulnerability.
Co-senior creator Dr. Rhys Farrer from the College of Exeter’s MRC Centre for Medical Mycology mentioned: “Till now, we’ve had no thought what genes are energetic throughout an infection of a dwelling host. We now want to seek out out if this additionally happens throughout human an infection. The truth that we discovered genes are activated to scavenge iron provides clues to the place Candida auris might originate, reminiscent of an iron-poor setting within the sea. It additionally provides us a possible goal for brand new and already present medicine.”
Hope for future remedies
Dr. Gifford, who additionally works as a resident doctor in intensive care and respiratory drugs on the Royal Devon & Exeter Hospital, emphasised the potential medical influence of the findings. He mentioned: “Whereas there are a selection of analysis steps to undergo but, our discovering could possibly be an thrilling prospect for future remedy. We’ve got medicine that concentrate on iron scavenging actions. We now must discover whether or not they could possibly be repurposed to cease Candida auris from killing people and shutting down hospital intensive care models.”
The Arabian killifish larvae mannequin was developed with help from an NC3Rs mission grant as a substitute for utilizing mouse and zebrafish fashions, that are generally employed to check how pathogens work together with their hosts.
Dr. Katie Bates, NC3Rs Head of Analysis Funding, mentioned: “This new publication demonstrates the utility of the alternative mannequin to check Candida auris an infection and allow unprecedented insights into mobile and molecular occasions in dwell contaminated hosts. This can be a sensible instance of how modern various approaches can overcome key limitations of conventional animal research.”
Reference: “Xenosiderophore transporter gene expression and clade-specific filamentation in Candida auris killifish (Aphanius dispar) an infection” 19 December 2025, Communications Biology.
DOI: 10.1038/s42003-025-09321-z
